Cita APA

Ballester, B., Milara, J., & Cortijo, J. (2020). Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation. Oncotarget.

Citación estilo Chicago

Ballester, Beatriz, Javier Milara, y Julio Cortijo. "Pirfenidone Anti-fibrotic Effects Are Partially Mediated By the Inhibition of MUC1 Bioactivation." Oncotarget 2020.

Cita MLA

Ballester, Beatriz, Javier Milara, y Julio Cortijo. "Pirfenidone Anti-fibrotic Effects Are Partially Mediated By the Inhibition of MUC1 Bioactivation." Oncotarget 2020.